RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+9.94%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$928M
AUM Growth
+$928M
(+1.6%)
Cap. Flow
-$37.6M
Cap. Flow
% of AUM
-4.05%
Top 10 Holdings %
Top 10 Hldgs %
57.36%
Holding
71
New
15
Increased
6
Reduced
13
Closed
13
Top Buys
| 1 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
$102M |
| 2 |
Collegium Pharmaceutical
COLL
|
$27.6M |
| 3 |
Ardelyx
ARDX
|
$27.5M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$23.3M |
| 5 |
MDCO
Medicines Co
MDCO
|
$20.2M |
Top Sells
| 1 |
BioCryst Pharmaceuticals
BCRX
|
$64.5M |
| 2 |
Arbutus Biopharma
ABUS
|
$47.4M |
| 3 |
Dynavax Technologies
DVAX
|
$43M |
| 4 |
DYAX
DYAX CORPORATION
DYAX
|
$39.9M |
| 5 |
Larimar Therapeutics
LRMR
|
$29M |
Sector Composition
| 1 | Healthcare | 81.38% |
